Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.47T | 33.4x | 1.83 | SEK 1,607 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 110.45B | 28.3x | 0.54 | SEK 320.80 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 39.52B | 91.3x | -22.76 | SEK 671.50 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 25.29B | 187.4x | -4.11 | SEK 381 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 21.11B | 111.4x | 1.22 | SEK 39.50 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 12.54B | 35.6x | -9.17 | SEK 124 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.5% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 6.93B | 69.8x | 1 | SEK 43.48 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.67B | -14.5x | -0.23 | SEK 46.99 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.8% Upside | Upgrade to Pro+ | |
IRLAB Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 726.16M | -8.7x | -0.17 | SEK 14 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 703.93M | -10.2x | -1 | SEK 2.90 | 48.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Cinclus Pharma Holding AB | Stockholm | Healthcare | Pharmaceuticals | SEK 678.52M | -3.4x | -0.09 | SEK 14.08 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Magle Chemoswed | Stockholm | Healthcare | Pharmaceuticals | SEK 640.10M | 21.3x | 0.37 | SEK 33.40 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42% Upside | Upgrade to Pro+ | |
Orexo AB | Stockholm | Healthcare | Pharmaceuticals | SEK 565.89M | -2.8x | 0.05 | SEK 16.40 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.8% Upside | Upgrade to Pro+ | |
Infant Bacterial Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 515.96M | -3.8x | 1.78 | SEK 38.50 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dicot | Stockholm | Healthcare | Pharmaceuticals | SEK 488.28M | -5.3x | -0.23 | SEK 0.26 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moberg Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 432.85M | -1.4x | 0 | SEK 9.28 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.4% Upside | Upgrade to Pro+ | |
Lipum | Stockholm | Healthcare | Pharmaceuticals | SEK 356.37M | -7.9x | -0.16 | SEK 18.30 | 8.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.7% Downside | Upgrade to Pro+ | |
Cessatech AS | Spotlight | Healthcare | Pharmaceuticals | SEK 298.72M | -13.5x | -0.3 | SEK 15.99 | -6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipidor | Stockholm | Healthcare | Pharmaceuticals | SEK 256.22M | -0.4x | -0.32 | SEK 0.30 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Isofol Medical | Stockholm | Healthcare | Pharmaceuticals | SEK 252.61M | -6.3x | 0.35 | SEK 1.56 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corline Biomedical AB | Stockholm | Healthcare | Pharmaceuticals | SEK 248.58M | -9.6x | 0.01 | SEK 10.15 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enorama Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 146.95M | -2.9x | -0.06 | SEK 2.43 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivesto AB | Stockholm | Healthcare | Pharmaceuticals | SEK 138.28M | -1.5x | -0.02 | SEK 0.26 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pila Pharma AB | Stockholm | Healthcare | Pharmaceuticals | SEK 100.37M | -12.6x | SEK 3.68 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Elicera Therapeutics AB | Stockholm | Healthcare | Pharmaceuticals | SEK 82.82M | -5.4x | -0.13 | SEK 2.31 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncozenge AB | Stockholm | Healthcare | Pharmaceuticals | SEK 73.09M | -8.4x | -0.19 | SEK 6.32 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ExpreS2ion Biotech | Stockholm | Healthcare | Pharmaceuticals | SEK 69.65M | -1.2x | -0.03 | SEK 27 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Double Bond Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 42.63M | -2.7x | -0.14 | SEK 0.41 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Odi Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 36.60M | -8.8x | 1.06 | SEK 2.36 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XP Chemistries AB | Stockholm | Healthcare | Pharmaceuticals | SEK 21.28M | -1.2x | -0.04 | SEK 0.10 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipigon Pharmaceuticals AB | Stockholm | Healthcare | Pharmaceuticals | SEK 16.35M | -0.9x | -0.08 | SEK 0.11 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
QuiaPEG Pharmaceutical | Stockholm | Healthcare | Pharmaceuticals | SEK 5.21M | -0.4x | -0 | SEK 0.004 | -16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |